Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Development and validation of a simulator-based test in transurethral resection of bladder tumours (TURBEST)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Educational level and first-time PSA testing in general practice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Successful extraction of sperm cells after autologous bone marrow transplant: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ejakulationsforstyrrelser

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Organisk rejsningsbesvær

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Refined View on the Association Between Y-chromosome Microdeletions and Sperm Concentration

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Perspectives on a Global Change in Testicular Cancer Incidence

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations
Abstract Objective. The aim of this study was to assess patient preference regarding the length of treatment intervals of androgen deprivation therapy (ADT) with gonadotropin-releasing hormone agonists for prostate cancer. Material and methods. The study was conducted as a questionnaire-based, cross-sectional study at a large university hospital. A specific questionnaire was developed based on current literature, clinical experience and a pilot phase of the study. The primary endpoint was preferred treatment frequency. Secondary outcome measures included reasons for preferred treatment frequency, treatment satisfaction and side-effects. Overall, 238 men receiving ADT for prostate cancer were presented with the questionnaire between September 2011 and May 2012. Descriptive statistics, the chi-squared test and multiple regression were used for analyses. Results. In total, 176 questionnaires (74%) were available for analysis. A total of 38.1% of participants preferred frequent treatment ("Every month", "Every third month"), 32.4% preferred infrequent treatment ("Every sixth month", "Every twelfth month") and 29.6% stated that length of the treatment intervals made no difference (p = 0.37). Patients with disease progression were most likely to prefer frequent treatment (odds ratio 4.4, 95% confidence interval 1.9-10.4). Overall, 84.1% were satisfied with treatment while one patient (0.6%) was dissatisfied. Nine per cent indicated severe side-effects. Conclusions. Less frequent ADT treatment may help to lower the pressure on healthcare systems and may be of benefit for a large group of patients. However, it cannot be prescribed blindly without possibly affecting patient satisfaction. The choice of treatment intervals should be made in collaboration between the physician and the patient.
Original languageEnglish
JournalScandinavian Journal of Urology and Nephrology
Volume48
Issue number2
Pages (from-to)183-8
Number of pages6
ISSN0036-5599
DOIs
Publication statusPublished - Apr 2014

ID: 39005619